1.
Blood Coagul Fibrinolysis
; 27(6): 724-6, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26761579
RESUMO
Factor VII is a new coagulation factor replacement therapy. It has permitted the practice of invasive procedures which were up until recently associated with a huge risk of bleeding in patients with hemophilia with inhibitors. Our case illustrates factor replacement therapy failure in a 13-year-old child operated on for hepatic cysts associated with a pelvic cyst. Major bleeding occurred postoperatively requiring several transfusions, an increase in dosage of factor VII, and administration of a heavy dose of factor VIII as a last resort. This case highlights the possibility of failure of factor replacement therapies constituting a life-threatening situation in which alternatives are few.
Assuntos
Equinococose/sangue , Fator VIII/uso terapêutico , Fator VIIa/uso terapêutico , Hemofilia A/sangue , Hemorragia/terapia , Adolescente , Transfusão de Sangue , Equinococose/complicações , Equinococose/parasitologia , Equinococose/cirurgia , Hemofilia A/complicações , Hemofilia A/parasitologia , Hemofilia A/cirurgia , Hemorragia/sangue , Hemorragia/etiologia , Humanos , Masculino , Complicações Pós-Operatórias , Proteínas Recombinantes/uso terapêutico
2.
Pan Afr Med J
; 22: 259, 2015.
Artigo
em Francês
| MEDLINE
| ID: mdl-26958122